vimarsana.com

Page 5 - நகரம் ஆஃப் நம்பிக்கை தேசிய மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CERo Therapeutics Expands Leadership Team with Experts in Cell Therapy Development

Press release content from Business Wire. The AP news staff was not involved in its creation. CERo Therapeutics Expands Leadership Team with Experts in Cell Therapy Development April 15, 2021 GMT SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Apr 15, 2021 CERo Therapeutics, Inc., a biopharmaceutical company pioneering the development of novel autologous engineered immune cellular therapies, today announced the expansion of the company’s leadership team with the addition of Remus Vezan, M.D., Ph.D. as Chief Medical Officer (CMO) and John Rossi, M. Sci. as Senior Vice President and Head of Translational Medicine. Dr. Vezan and Mr. Rossi have been instrumental in the successful development of marketed CAR T-cell therapies in their prior roles. At CERo, they will lead the company’s clinical development efforts to rapidly advance its T cell engineering platform and next-generation cell therapy products. CERo’s novel approach combines elements of both innate and adaptive immune res

Shared decision-making: Is it harmful for lung cancer screening?

April 14, 2021 On March 9, AuntMinnie.com reported that the U.S. Preventive Services Task Force (USPSTF) had doubled down on its recommendation for shared decision-making in CT lung cancer screening, prompting the question among critics of exactly how useful shared decision-making is for this particular use. Dr. Fred Grannis Jr. To address the question, it is necessary to review the history of shared decision-making and decision aids for lung cancer screening. As I have earlier reported on AuntMinnie.com, 1 the idea of shared decision-making originated with Dr. Peter Bach, who had served as senior advisor to the director of the U.S. Centers for Medicare and Medicaid Services (CMS).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.